Nuvaring Insert, Extended Release
Product Images NDC 78206-146

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Nuvaring (NDC 78206-146). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Nuvaring 01)

FDA Label Image

Nuvaring 01a

FDA Label Image

Chemical Structure (Nuvaring 02)

FDA Label Image

Figure 2 (Nuvaring 03)

FDA Label Image

Figure 3 (Nuvaring 04)

Figure 3 (Nuvaring 04)
This appears to be a table or chart showing different methods of birth control and their effectiveness rates. The table shows that there are different levels of effectiveness for different methods, with some methods such as sterilization and intrauterine devices being among the most effective with fewer than 1 pregnancy per 100 women per year, while other methods such as birth control pills and condoms are less effective with 10-20 pregnancies per 100 women in one year. The chart also lists different methods of birth control including injections, sterilization, birth control pills, and the use of spermicide or withdrawal, among others. Lastly, it suggests that abstinence during fertile days is also a method of birth control but notes that having no birth control is not a recommended option.*
FDA Label Image

Figure 4 (Nuvaring 05)

FDA Label Image

Figure A, Figure B, Figure C (Nuvaring 06)

FDA Label Image

Figure D, Figure E (Nuvaring 07)

FDA Label Image

Figure F (Nuvaring 08)

Figure F (Nuvaring 08)
This appears to be a diagram or list of some sort indicating three items: "Uterus", "Vagina", and "NuvaRing®". Without further context or clarity, it is not possible to provide a useful description of what this text is referring to or how it may be useful.*
FDA Label Image

Figure G (Nuvaring 09)

FDA Label Image

Figure H (Nuvaring 10)

FDA Label Image

Figure I (Nuvaring 11)

FDA Label Image

Figure J (Nuvaring 12)

FDA Label Image

Principle Display Panel (3 Ring Pouch Carton)

Principle Display Panel (3 Ring Pouch Carton)
This appears to be a description of a NUVARING package. The package has a tamper-evident seal and a unique product code (GTN:00378206146038). The package is for vaginal use only and users are advised not to use the product if the seal is broken. The package contains one ring that is used for a 3-week period. The ingredients include 0.120 mg/day of etonogestrel and 0.015 mg/day of ethinyl estradiol. The manufacturer is Organon Global Inc., a subsidiary of Organon & Co. The package also includes a space for a 2D serialization barcode, serial number, expiry, and lot number.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.